Correlation Between Inhibrx and Living Cell

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Living Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Living Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Living Cell Technologies, you can compare the effects of market volatilities on Inhibrx and Living Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Living Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Living Cell.

Diversification Opportunities for Inhibrx and Living Cell

0.13

Correlation Coefficient

Inhibrx  Living Cell

Average diversification

The 3 months correlation between Inhibrx and Living is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Living Cell Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Living Cell Technologies and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Living Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Living Cell Technologies has no effect on the direction of Inhibrx i.e., Inhibrx and Living Cell go up and down completely randomly.

Pair Corralation between Inhibrx and Living Cell

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Living Cell. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 7.43 times less risky than Living Cell. The stock trades about -0.07 of its potential returns per unit of risk. The Living Cell Technologies is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  0.51  in Living Cell Technologies on October 25, 2024 and sell it today you would lose (0.17) from holding Living Cell Technologies or give up 33.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	85.71%
Values	Daily Returns

Inhibrx  vs.  Living Cell Technologies

Inhibrx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Living Cell Technologies

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Living Cell Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Living Cell reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Inhibrx and Living Cell

The main advantage of trading using opposite Inhibrx and Living Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Living Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Living Cell will offset losses from the drop in Living Cell's long position.

The idea behind Inhibrx and Living Cell Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.